Available option
10mg / 1.2mL
Staff-prepared solution
- Strength
- 10mg / 1.2mL
- Format
- Staff-prepared solution
Bear Biotech catalogue
BPC-157
Pentadecapeptide cell and vascular signalling research
- Tissue integrity
- Vascular signalling
- Gastrointestinal models
Available presentations
Choose a strength and format
Each available presentation is listed separately. Current prices are confirmed from the Bear Biotech catalogue.
Available option
10mg
Lyophilised powder
- Strength
- 10mg
- Format
- Lyophilised powder
Research overview
What is BPC-157?
BPC-157 sits at the centre of experimental tissue-repair research, with preclinical studies spanning tendon, ligament, muscle, vascular and gastrointestinal injury models. Researchers are particularly interested in tissue integrity, angiogenic signalling and protective-response pathways. Human evidence remains limited, so Bear Biotech presents BPC-157 strictly as laboratory research material.
Predominantly preclinical
Research focus
Key research areas
BPC-157 research: why it attracts attention
BPC-157 literature examines a defined pentadecapeptide in cell and animal models of tissue integrity, angiogenic signalling and gastrointestinal biology. The evidence remains predominantly preclinical. Published findings concern defined experimental materials and do not establish the identity, quality, safety, efficacy or equivalence of Bear Biotech catalogue material.
- Tissue integrity
- Vascular signalling
- Gastrointestinal models
Representative primary research
Representative research
A preclinical study examined BPC-157 in endothelial-cell, membrane and rat hind-limb models.
- Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation ↗ Original preclinical research; it does not establish a human outcome.
These sources provide research context only. They do not verify the identity, quality or equivalence of a Bear Biotech catalogue batch; the matched lot-specific batch record remains controlling.
Specifications
Product information
- Material identity
- BPC-157
- Research category
- Pentadecapeptide cell and vascular signalling research
- Evidence position
- Predominantly preclinical
- Recorded formats
- Staff-prepared solution · Lyophilised powder
- Batch-record basis
- The matched lot-specific record controls identity and analytical claims.
- Intended use
- Controlled laboratory research only.
Research questions
Evidence and identity questions
Why is BPC-157 examined in tissue-integrity and repair-signalling models?
Tissue-integrity models let researchers examine how BPC-157 relates to cellular protection, repair signalling and structural responses after experimental injury. These questions remain preclinical.
What do vascular and gastrointestinal models contribute to BPC-157 research?
Vascular signalling studies focus on angiogenic and endothelial responses, while gastrointestinal models examine barrier and protective-response biology. Together they define the main experimental contexts rather than a proven human use.
Why does BPC-157 evidence remain predominantly preclinical?
BPC-157 evidence is predominantly preclinical and depends on the exact experimental material, model and endpoint. It does not establish a clinical treatment outcome.
Batch documentation
Lot-specific records stay connected to the order
Eligible lot-specific documentation may be viewed or requested from the registered Bear Biotech account when available for the applicable order.
Open Bear Biotech accountResearch use only
Controlled laboratory research material
Not for human or veterinary consumption. Administration, dosing and therapeutic guidance are not provided.